As a young and forward thinking company with a rich heritage, Astellas is dedicated to improving peoples’ lives through the introduction of innovative and reliable pharmaceutical products. In Europe, Astellas’ strategic focus and core expertise lie in Transplantation, Urology, Dermatology, Anti-Infectives and Pain Management and it is committed to developing a strong presence in Oncology.
New medicines for use in Urology are currently under evaluation through a major R&D; programme. By focusing our resources and expertise in areas of Urology that still have unmet medical needs, Astellas Europe leads the way in developing pioneering treatments for conditions such as Benign Prostatic Hyperplasia (BPH), Prostate Cancer, and Overactive Bladder (OAB), offering hope to patients.
|
